Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S5H6U0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.500 |
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.416 |
CLV_NRD_NRD_1 | 237 | 239 | PF00675 | 0.521 |
CLV_NRD_NRD_1 | 323 | 325 | PF00675 | 0.533 |
CLV_NRD_NRD_1 | 381 | 383 | PF00675 | 0.508 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.424 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.484 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.392 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 323 | 325 | PF00082 | 0.500 |
CLV_PCSK_KEX2_1 | 381 | 383 | PF00082 | 0.379 |
CLV_PCSK_PC1ET2_1 | 126 | 128 | PF00082 | 0.536 |
CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.424 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.390 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.502 |
CLV_PCSK_PC1ET2_1 | 185 | 187 | PF00082 | 0.514 |
CLV_PCSK_PC7_1 | 156 | 162 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.437 |
DEG_APCC_DBOX_1 | 160 | 168 | PF00400 | 0.355 |
DEG_APCC_DBOX_1 | 185 | 193 | PF00400 | 0.506 |
DEG_APCC_DBOX_1 | 2 | 10 | PF00400 | 0.425 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.533 |
DEG_SCF_FBW7_1 | 46 | 53 | PF00400 | 0.445 |
DOC_CDC14_PxL_1 | 164 | 172 | PF14671 | 0.345 |
DOC_CKS1_1 | 47 | 52 | PF01111 | 0.446 |
DOC_CYCLIN_yCln2_LP_2 | 137 | 143 | PF00134 | 0.321 |
DOC_CYCLIN_yCln2_LP_2 | 251 | 257 | PF00134 | 0.495 |
DOC_MAPK_gen_1 | 18 | 24 | PF00069 | 0.432 |
DOC_MAPK_gen_1 | 209 | 217 | PF00069 | 0.342 |
DOC_MAPK_gen_1 | 237 | 244 | PF00069 | 0.470 |
DOC_MAPK_JIP1_4 | 238 | 244 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 100 | 109 | PF00069 | 0.515 |
DOC_MAPK_MEF2A_6 | 210 | 219 | PF00069 | 0.335 |
DOC_MAPK_MEF2A_6 | 26 | 33 | PF00069 | 0.424 |
DOC_MAPK_NFAT4_5 | 26 | 34 | PF00069 | 0.430 |
DOC_PP2B_LxvP_1 | 251 | 254 | PF13499 | 0.418 |
DOC_PP4_FxxP_1 | 348 | 351 | PF00568 | 0.334 |
DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.440 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.328 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.444 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.499 |
DOC_WW_Pin1_4 | 376 | 381 | PF00397 | 0.499 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.358 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.451 |
LIG_14-3-3_CanoR_1 | 184 | 190 | PF00244 | 0.456 |
LIG_BRCT_BRCA1_1 | 120 | 124 | PF00533 | 0.449 |
LIG_BRCT_BRCA1_1 | 261 | 265 | PF00533 | 0.348 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.388 |
LIG_BRCT_BRCA1_2 | 120 | 126 | PF00533 | 0.545 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.485 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.446 |
LIG_FHA_2 | 254 | 260 | PF00498 | 0.570 |
LIG_LIR_Nem_3 | 285 | 291 | PF02991 | 0.336 |
LIG_Pex14_2 | 148 | 152 | PF04695 | 0.453 |
LIG_Pex14_2 | 348 | 352 | PF04695 | 0.338 |
LIG_REV1ctd_RIR_1 | 96 | 102 | PF16727 | 0.397 |
LIG_SH2_NCK_1 | 358 | 362 | PF00017 | 0.456 |
LIG_SH2_SRC | 141 | 144 | PF00017 | 0.290 |
LIG_SH2_STAP1 | 146 | 150 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.403 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.458 |
LIG_SH3_3 | 137 | 143 | PF00018 | 0.346 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.435 |
LIG_SH3_3 | 247 | 253 | PF00018 | 0.432 |
LIG_SUMO_SIM_anti_2 | 395 | 403 | PF11976 | 0.351 |
LIG_TRAF2_1 | 188 | 191 | PF00917 | 0.506 |
LIG_TRAF2_1 | 220 | 223 | PF00917 | 0.390 |
LIG_TRAF2_1 | 256 | 259 | PF00917 | 0.579 |
MOD_CDK_SPK_2 | 376 | 381 | PF00069 | 0.533 |
MOD_CDK_SPxK_1 | 376 | 382 | PF00069 | 0.528 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.448 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.469 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.376 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.445 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.445 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.521 |
MOD_Cter_Amidation | 235 | 238 | PF01082 | 0.541 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.458 |
MOD_GlcNHglycan | 246 | 250 | PF01048 | 0.427 |
MOD_GlcNHglycan | 392 | 395 | PF01048 | 0.320 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.432 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.459 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.358 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.331 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.445 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.433 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.460 |
MOD_NEK2_1 | 392 | 397 | PF00069 | 0.326 |
MOD_NEK2_1 | 67 | 72 | PF00069 | 0.493 |
MOD_PKA_1 | 185 | 191 | PF00069 | 0.514 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.514 |
MOD_Plk_1 | 128 | 134 | PF00069 | 0.433 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.493 |
MOD_ProDKin_1 | 376 | 382 | PF00069 | 0.494 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.359 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.450 |
MOD_SUMO_for_1 | 159 | 162 | PF00179 | 0.392 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.306 |
TRG_ER_diArg_1 | 184 | 187 | PF00400 | 0.494 |
TRG_ER_diArg_1 | 237 | 239 | PF00400 | 0.524 |
TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 322 | 324 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 380 | 382 | PF00400 | 0.514 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUB7 | Leptomonas seymouri | 79% | 100% |
A0A0S4JDZ8 | Bodo saltans | 61% | 100% |
A0A422NT95 | Trypanosoma rangeli | 59% | 100% |
A4H7Z7 | Leishmania braziliensis | 92% | 100% |
A4HWC5 | Leishmania infantum | 100% | 100% |
C9ZUV7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 99% |
D1AB74 | Thermomonospora curvata (strain ATCC 19995 / DSM 43183 / JCM 3096 / KCTC 9072 / NBRC 15933 / NCIMB 10081 / Henssen B9) | 24% | 100% |
E9AQ25 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
O26884 | Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) | 26% | 100% |
O62742 | Oryctolagus cuniculus | 31% | 74% |
P07857 | Bos taurus | 28% | 75% |
P11915 | Rattus norvegicus | 29% | 74% |
P22307 | Homo sapiens | 28% | 74% |
P32020 | Mus musculus | 27% | 74% |
Q4QFF6 | Leishmania major | 95% | 100% |
Q58944 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 24% | 100% |
V5BHW0 | Trypanosoma cruzi | 62% | 87% |